ema glp-1 vision loss recommendation november 2025 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January EMA finds no link between

ZONES TRAITES PAR LA LIPOSCULPTURE Cou Seins Partie suprieure du bras Estomac Bas-ventre Hanches Partie entre bas-ventre et hanches Pubis Culotte de cheval (partie latrale des cuisses) Intrieur cuisses (partie suprieure) Partie frontale cuisses Intrieur cuisses (partie infrieure) Partie frontale genoux Intrieur genoux Nuque Omoplates Rouleaux dorsaux (en-dessous du soutien gorge) Rouleaux de la taille (poignes damour) Partie infrieure du dos Dessus du coccyx Fesses Plis fessiers Cuisses postrieures

and chemical and genetic inhibition of mTORC1 signaling sensitized cancer cells to ferroptosis

Whats happening is that the collagen in the skin is breaking down, and is not being replaced

This would remove the need for a needle in the GLP-1 weight loss process